Forecast: Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods in Spain

The healthcare expenditure on pharmaceuticals and medical non-durable goods in Spain has shown a fluctuating trend over the past decade. In 2023, it stood at 14.74 units of total current health expenditure, marking a slight decrease of 0.34% from the previous year. Over the last two years, the year-on-year variations reflect a mixed trend with a decline of 3.51% in 2021 followed by an increase of 1.65% in 2022. The five-year compound annual growth rate (CAGR) leading up to 2023 is -0.64%, indicating a slight but consistent reduction in expenditure.

Over the forecasted period from 2024 to 2028, expenditures are expected to continue their slow decline, with the five-year forecasted CAGR at -0.16%. The healthcare expenditure is projected to reach 14.57 units by 2028, reflecting an overall decrease of 0.82% over the five-year forecast period.

Future trends to watch for include:

• The impact of technological advancements and digital health solutions, which may alter expenditure patterns.
• Policy changes in healthcare funding and reimbursement models.
• The aging population and its associated rise in healthcare needs.
• Potential economic fluctuations that can influence public and private healthcare spending.